Clinical Trial Update: Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update shows completed study evaluating quetiapine extended-release for menopausal depression, including major depressive disorder, insomnia, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Quetiapine Extended Release (XR) (quetiapine)

Snippet

Sponsor: McMaster University | Conditions: Major Depressive Disorder, Insomnia | Phase 4 | Status: COMPLETED